![Rogério Vivaldi Coelho](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rogério Vivaldi Coelho
Directeur Général chez
SIGILON THERAPEUTICS, INC.
Fortune : 1 M $ au 31/05/2026
Profil
Rogério Vivaldi Coelho was the founder of Minerva Neurosciences, Inc., founded in 2007, where the title held was President, Chief Executive Officer & Director in 2014.
Current jobs include Chief Executive Officer at Sigilon Therapeutics, Inc. since 2023, Independent Director at Crinetics Pharmaceuticals, Inc. since 2022, and Independent Director at Viatris, Inc. since 2024.
Former jobs include Director at Mind-NRG SARL in 2014, President-Rare Disease, Renal & Endocrine, SVP at Genzyme Corp.
from 1997 to 2014, Chief Commercial Officer at Spark Therapeutics, Inc. from 2015 to 2016, and Chief Global Therapeutics Officer & Executive VP at Bioverativ, Inc. from 2016 to 2018.
Education history includes a doctorate from the Federal University of Rio de Janeiro and an MBA from COPPEAD Graduate School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/03/2026 | 46 526 ( 0 % ) | 756 513 $ | 31/05/2026 | |
| 20/04/2026 | 9 400 ( 0,01 % ) | 334 170 $ | 31/05/2026 |
Postes actifs de Rogério Vivaldi Coelho
| Sociétés | Poste | Début |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Directeur Général | 14/08/2018 |
| CRINETICS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 03/01/2022 |
| VIATRIS INC. | Directeur/Membre du Conseil | 03/06/2024 |
Anciens postes connus de Rogério Vivaldi Coelho
| Sociétés | Poste | Fin |
|---|---|---|
| BIOVERATIV INC | Corporate Officer/Principal | 01/01/2018 |
| SPARK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 05/01/2015 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| MINERVA NEUROSCIENCES, INC. | Fondateur | 20/11/2014 |
Mind-NRG SARL
 Mind-NRG SARL Medical/Nursing ServicesHealth Services Provides research and drug development services | Directeur/Membre du Conseil | 20/11/2014 |
Formation de Rogério Vivaldi Coelho
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Federal University of Rio de Janeiro
 Federal University of Rio de Janeiro Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mind-NRG SARL
Mind-NRG SARL Medical/Nursing ServicesHealth Services Provides research and drug development services | Health Services |
COPPEAD Graduate School of Business
 COPPEAD Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Minerva Neurosciences, Inc.
 Minerva Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes drugs to treat patients suffering from central nervous system diseases | Health Technology |
Crinetics Pharmaceuticals, Inc.
 Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic treatments for chronic diseases | Health Technology |
Viatris, Inc.
 Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
